We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Craven House Capital Plc | LSE:CRV | London | Ordinary Share | GB00BD4FQ360 | ORD USD1.00 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.20 | 0.15 | 0.25 | 0.20 | 0.176 | 0.20 | 0.00 | 08:00:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | -5.26M | -5.52M | -1.4274 | -0.14 | 772.72k |
TIDMCRV
RNS Number : 6972P
Craven House Capital PLC
21 November 2016
21(st) November 2016
Craven House Capital plc ("Craven House" or the "Company")
Cash placing of 240,000 new ordinary shares at $12.50 per share
Craven House Capital (AIM: CRV) announces that it has raised $3,000,000 in cash (before expenses), through a placing (the "Placing") of 240,000 new ordinary shares of $1.00 each in the Company ("Placing Shares") at a price of $12.50 per Placing Share ("Placing Price").
The net proceeds of the Placing will be used to further execute the Company's investment policy. A number of prospective investment opportunities in our target markets are currently under evaluation and further updates will be provided to the market in due course.
Further to previous announcements, the Company is continuing its discussions with additional prospective investors with regard to making investments in the Company via further subscriptions for new shares and updates will be provided to the market in due course.
Application will be made for the Placing Shares, which will rank pari passu with the existing ordinary shares in the Company, to be admitted to trading on AIM. It is expected that Admission will become effective and dealings will commence at 8.00 a.m. on 25 November 2016.
Following Admission the total issued share capital will consist of 2,464,362 ordinary shares. As such the total number of voting rights in the Company will be 2,464,362 ordinary shares. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
Ends
For further information please contact:
Craven House Capital Plc Tel: 020 7002 1027 Mark Pajak www.Cravenhousecapital.com SI Capital Tel: 01483 413500 Broker Nick Emerson www.sicapital.co.uk SPARK Advisory Partners Tel: 0203 368 3550 Limited Nominated Adviser Matt Davis/Mark Brady www.Sparkadvisorypartners.com
About Craven House Capital:
Craven House Capital is a frontier and emerging market focused merchant bank seeking value oriented long term investments. Craven House invests in all segments of the capital structure in partnership with local entrepreneurs and the local business community. Craven House provides long term patient capital and is often involved in restructuring, expansion and turn around investments in crisis and transitioning economies.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGIBDBGUDBGLB
(END) Dow Jones Newswires
November 21, 2016 03:57 ET (08:57 GMT)
1 Year Craven House Capital Chart |
1 Month Craven House Capital Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions